Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-30

Clinical Trial Update: Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing etoricoxib with aceclofenac in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aceclofenac (Aceclofenac)
  • Etoricoxib (etoricoxib)

Snippet

Sponsor: Chung Shan Medical University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED